Pharma Focus Asia
258 FOLLOWERS
Covers articles related to manufacturing, clinical trials, research and development, strategy, Information technology. Pharma Focus Asia, published by Ochre Media, is the leading pharma title in print and digital versions serving the information needs of key executives from the worlds leading pharmaceutical companies.
Pharma Focus Asia
2d ago
Kynos Therapeutics Ltd a clinical stage biotechnology company developing firstinclass small molecule ..read more
Pharma Focus Asia
2d ago
Lantern Pharma Inc an artificial intelligence company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning ..read more
Pharma Focus Asia
2d ago
Bristol Myers Squibb and Cellares the first Integrated Development and Manufacturing Organization ..read more
Pharma Focus Asia
2d ago
Innocan Pharma Corporation is pleased to announce that is has reached a key milestone the Company submitted its letter of application for a PreIND meeting ..read more
Pharma Focus Asia
2d ago
Tiziana Life Sciences Ltd recently announced a significant development regarding its lead candidate foralumab in a study highlighted by Neurology Today the official news source of the American Academy ..read more
Pharma Focus Asia
2d ago
ProQR Therapeutics NV has once again successfully defended a crucial patent for its groundbreaking RNA editing platform Axiomer This achievement follows the companys victory in fending off opposition against its key patent EP B filed with the European Patent Office ..read more
Pharma Focus Asia
2d ago
BGI Genomics a renowned leader in precision medicine solutions has launched a cuttingedge clinical laboratory in Uruguays Parque de las Ciencias free trade zone This move is poised to advance preventive ..read more
Pharma Focus Asia
2d ago
OSR Holdings a significant global healthcare holding company has recently announced the signing of a memorandum of understanding with SillaJen a biotech firm listed on Kosdaq and renowned for its pipeline ..read more
Pharma Focus Asia
2d ago
Enlivex Therapeutics Ltd has commenced dosing for the initial two patients in its Phase III trial evaluating AllocetraTM for moderate to severe knee osteoarthritis This multicountry trial aims ..read more
Pharma Focus Asia
1w ago
Boundless Bio a clinicalstage oncology company interrogating extrachromosomal DNA biology to deliver transformative therapies to patients with previously intractable oncogeneamplified cancers ..read more